Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE for Sarcoma metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 33 adverse event reports in the FDA FAERS database where GEMCITABINE was used for Sarcoma metastatic.

Most Reported Side Effects for GEMCITABINE

Side Effect Reports % Deaths Hosp.
Off label use 3,319 10.6% 496 1,162
Disease progression 3,123 10.0% 558 411
Thrombocytopenia 2,320 7.4% 271 875
Drug ineffective 2,003 6.4% 486 431
Malignant neoplasm progression 1,962 6.3% 602 411
Neutropenia 1,892 6.0% 235 512
Anaemia 1,745 5.6% 223 820
Pyrexia 1,511 4.8% 148 1,102
Nausea 1,336 4.3% 146 650
Myelosuppression 1,197 3.8% 50 559
Fatigue 1,098 3.5% 124 440
Febrile neutropenia 1,082 3.5% 264 653
Diarrhoea 1,074 3.4% 179 603
Vomiting 1,016 3.2% 116 645
Neoplasm progression 960 3.1% 239 175

Other Indications for GEMCITABINE

Pancreatic carcinoma (2,706) Diffuse large b-cell lymphoma (2,506) Product used for unknown indication (2,401) Pancreatic carcinoma metastatic (1,586) Cholangiocarcinoma (1,181) Adenocarcinoma pancreas (1,089) Bladder cancer (841) Transitional cell carcinoma (825) Ovarian cancer (648) Non-small cell lung cancer (634)

Other Drugs Used for Sarcoma metastatic

DOXORUBICIN (114) TRABECTEDIN (53) IFOSFAMIDE (49) DOCETAXEL (39) PAZOPANIB (39) MESNA (23) GEMCITABINE\GEMCITABINE (21) OLARATUMAB (21) VINCRISTINE (20) PEMBROLIZUMAB (18)

Related Pages

GEMCITABINE Full Profile All Sarcoma metastatic Drugs GEMCITABINE Demographics GEMCITABINE Timeline